Veeva Systems (VEEV) Stock Price, News & Analysis

Company Overview

Veeva Systems Inc. is a cloud software company that provides technology solutions for the life sciences industry, including pharmaceutical, biotechnology, medical device and related organizations. Its applications are designed to support functions across the product lifecycle, from research and clinical development through regulatory approval, manufacturing, quality management and commercial operations.

The company’s Veeva Vault platform includes applications for clinical data management, electronic trial management, regulatory information, quality processes, safety operations and commercial content management. Veeva also offers customer relationship management, data and analytics products, and industry-specific applications intended to help life sciences companies manage information, collaborate with stakeholders and meet regulatory requirements.

Founded in 2007 by Peter Gassner and Matt Wallach, Veeva serves customers globally, with operations and clients across North America, Europe, Asia-Pacific and other international markets. The company is headquartered in Pleasanton, California, and focuses its business exclusively on cloud-based software and services for the life sciences sector.

Key Stats

• Today's Range: $262.44 to $267.96
• 50-Day Range: $179.36 to $285.56
• 52-Week Range: $148.05 to $310.50
• Volume: 1.11 million shs
• Average Volume: 1.70 million shs
• Market Capitalization: $42.88 billion
• P/E Ratio: 43.56
• Dividend Yield: N/A
• Price Target: $284.88
• Consensus Rating: Moderate Buy

Veeva Systems Stock Analysis - MarketRank™

Veeva Systems scored higher than 88% of companies evaluated by MarketBeat, and ranked 105th out of 903 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.9 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Veeva Systems has received a consensus rating of Moderate Buy. The company's average rating score is 2.64, and is based on no strong buy ratings, 19 buy ratings, 8 hold ratings, and 1 sell rating.

Upside/Downside

The consensus price target for Veeva Systems is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

Veeva Systems has been the subject of 19 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 11.49%

Earnings Growth

Earnings for Veeva Systems are expected to grow by 11.49% in the coming year, from $6.70 to $7.47 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Veeva Systems is 43.56, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.57.

Price to Earnings Ratio vs. Sector

The P/E ratio of Veeva Systems is 43.56, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 273.52.

Price to Earnings Growth Ratio

Veeva Systems has a PEG Ratio of 1.14. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Veeva Systems has a P/B Ratio of 5.77. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.33% of the float of Veeva Systems has been sold short.

Short Interest Ratio / Days to Cover

Veeva Systems has a short interest ratio ("days to cover") of 2.19, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Veeva Systems has recently decreased by 17.46%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Veeva Systems does not currently pay a dividend.

Dividend Growth

Veeva Systems does not have a long track record of dividend growth.

News and Social Media

• Score: 4.4 / 5
• News Sentiment: 1.08

News Sentiment

Veeva Systems has a news sentiment score of 1.08. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.78 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 21 news articles for Veeva Systems this week, compared to 9 articles on an average week.

Search Interest

27 people have searched for VEEV on MarketBeat in the last 30 days. This is an increase of 35% compared to the previous 30 days.

MarketBeat Follows

18 people have added Veeva Systems to their MarketBeat watchlist in the last 30 days. This is an increase of 64% compared to the previous 30 days.

Company Ownership

• Score: 1.8 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Veeva Systems insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $12,017,360.00 in company stock.

Percentage Held by Insiders

10.60% of the stock of Veeva Systems is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

88.20% of the stock of Veeva Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/26/2026
• Today: 9/17/2026
• Next Earnings (Estimated): 11/25/2026
• Fiscal Year End: 1/31/2027

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Technology
• Sub-Industry: Healthcare Technology
• Current Symbol: NYSE:VEEV
• CIK: 1393052
• Web: www.veeva.com
• Phone: (925) 452-6500
• Fax: 925-452-6504
• Employees: 7,928
• Year Founded: 2007

Price Target and Rating

• Average Price Target for Veeva Systems: $284.88
• High Price Target: $340.00
• Low Price Target: $165.00
• Potential Upside/Downside: +7.6%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.64
• Research Coverage: 28 Analysts

Profitability

• EPS (Trailing Twelve Months): $6.08
• Trailing P/E Ratio: 43.56
• Forward P/E Ratio: 39.53
• P/E Growth: 1.14
• Net Income: $908.91 million
• Net Margins: 29.34%
• Pretax Margin: 38.38%
• Return on Equity: 14.25%
• Return on Assets: 11.71%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 5.46
• Quick Ratio: 5.46

Sales & Book Value

• Annual Sales: $3.20 billion
• Price / Sales: 13.42
• Cash Flow: $6.21 per share
• Price / Cash Flow: 42.65
• Book Value: $45.90 per share
• Price / Book: 5.77

Miscellaneous

• Outstanding Shares: 161,910,000
• Free Float: 144,747,000
• Market Cap: $42.88 billion
• Optionable: Optionable
• Beta: 0.97